Clinical trial
A Multi-center, Randomized, Double-blind, Double-dummy Parallel-controlled Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)
NCT01537250 is registered in ClinicalTrials.gov with TaiGen Biotechnology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Double-blind, Double-dummy Parallel-controlled Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)
- Lead sponsor
- TaiGen Biotechnology Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- August 31, 2010
- Enrollment
- 192 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.